DNA Script: Enzymatic DNA Synthesis and European Biological Sovereignty
Strategic mapping of DNA Script’s SYNTAX platform. Enabling rapid on-site DNA synthesis for sovereign biothreat detection, medical readiness, and DNA data storage.
DNA Script SAS is a Paris-based deep-tech biotechnology company specializing in enzymatic DNA synthesis[1]. Founded in 2014, it has developed the SYNTAX® platform, the world’s first benchtop DNA “printer,” enabling rapid on-site production of custom oligonucleotides for research and diagnostics. Headquartered in Le Kremlin-Bicêtre (Paris metropolitan ar…

